GB0910605D0 - A pharmaceutical composition comprising at least one hormone antagonist and at least one bioreductive prodrug and their use - Google Patents

A pharmaceutical composition comprising at least one hormone antagonist and at least one bioreductive prodrug and their use

Info

Publication number
GB0910605D0
GB0910605D0 GB0910605A GB0910605A GB0910605D0 GB 0910605 D0 GB0910605 D0 GB 0910605D0 GB 0910605 A GB0910605 A GB 0910605A GB 0910605 A GB0910605 A GB 0910605A GB 0910605 D0 GB0910605 D0 GB 0910605D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
hormone antagonist
bioreductive
prodrug
bioreductive prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0910605A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ulster University
Original Assignee
Ulster University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulster University filed Critical Ulster University
Priority to GB0910605A priority Critical patent/GB0910605D0/en
Publication of GB0910605D0 publication Critical patent/GB0910605D0/en
Ceased legal-status Critical Current

Links

GB0910605A 2009-06-19 2009-06-19 A pharmaceutical composition comprising at least one hormone antagonist and at least one bioreductive prodrug and their use Ceased GB0910605D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0910605A GB0910605D0 (en) 2009-06-19 2009-06-19 A pharmaceutical composition comprising at least one hormone antagonist and at least one bioreductive prodrug and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0910605A GB0910605D0 (en) 2009-06-19 2009-06-19 A pharmaceutical composition comprising at least one hormone antagonist and at least one bioreductive prodrug and their use

Publications (1)

Publication Number Publication Date
GB0910605D0 true GB0910605D0 (en) 2009-07-29

Family

ID=40941093

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0910605A Ceased GB0910605D0 (en) 2009-06-19 2009-06-19 A pharmaceutical composition comprising at least one hormone antagonist and at least one bioreductive prodrug and their use

Country Status (1)

Country Link
GB (1) GB0910605D0 (en)

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and administration thereof
IL212599A0 (en) Pharmaceutical dosage form comprising nifedipine or nisoldipine and an angiotensin-ii antagonist and/or a diuretic
IL207128A0 (en) Pharmaceutical dosage form
AP2010005341A0 (en) Solid pharmaceutical dosage form
IL219722A0 (en) Pharmaceutical composition comprising a glp-1 agonist and methionine
IL216374A0 (en) Compositions and methods for drug delivery
SG175137A1 (en) Drug delivery composition
SMT202200129T1 (en) Pharmaceutical composition comprising drospirenone for use as a contraceptive
IL216256A0 (en) A pharmaceutical composition
ZA200903854B (en) A gastroretentive pharmaceutical dosage form
SI2154966T1 (en) Benzimidazoles and pharmaceutical compositions thereof
IL247086A0 (en) Nitrogen-containing compounds and pharmaceutical compositions
IL204528A (en) Combined sustained and immediate release metadoxine pharmaceutical dosage forms
LT2437748T (en) Combination preparation comprising a cytokine antagonist and a corticosteroid
IL217927A (en) Azaheterocyclic compounds and pharmaceutical compositions and set comprising them
ZA201105572B (en) Pharmaceutical composition for oral administration
ZA200903858B (en) Pharmaceutical dosage form
IL219617A0 (en) Pharmaceutical solid dosage form
ZA201008115B (en) A solid pharmaceutical formulation
IL219963A (en) Pharmaceutical composition comprising transnorsertraline hydrochloride and mannitol and uses thereof
GB0902648D0 (en) Pharmaceutical compounds and compositions
ZA200908494B (en) A controlled release intravaginal polymeric pharmaceutical dosage form
HU0900482D0 (en) Pharmaceutical formulation for oral administration
EP2529755A4 (en) Pharmaceutical composition and preparation for oral administration
GB0908317D0 (en) Pharmaceutical compounds and compositions

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)